The effect of sarcopenic obesity on glycaemic status based on fasting plasma glucose and glycated haemoglobin: A prospective cohort study
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16016 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Yiling Lou und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Sarcopenia, Glycated Hemoglobin, Obesity, Blood Glucose. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Huazhong University of Science and Technology, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Aim
To investigate the effect of sarcopenic obesity on the progression of glycaemic status in middle‐aged and older adults without diabetes. Materials and Methods This research involved 4637 participants without diabetes from the China Health and Retirement Longitudinal Study 2011–2015. Sarcopenic obesity at baseline was evaluated based on the Asian Working Group for Sarcopenia 2019 criteria. According to the American Diabetes Association criteria, we used fasting plasma glucose and glycated haemoglobin to define glycaemic status. Cox proportional hazard models were applied to obtain adjusted hazard ratios (HRs) and 95% confidence intervals (CIs).
Results
The mean age of included participants was 58.98 ± 8.82 years, and 45.35% were men. During 18,497 person‐years of follow‐up, 1743 (37.59%) cases with glycaemic status progression were identified. Compared with participants without sarcopenia and obesity, participants with sarcopenic obesity, but not sarcopenia only or obesity only, exhibited a higher risk of progression from normoglycaemia to diabetes (HR = 2.11; 95% CI: 1.10–4.04). Moreover, participants with sarcopenic obesity (HR = 1.65; 95% CI: 1.04–2.63), sarcopenia only (HR = 1.78; 95% CI: 1.11–2.86), or obesity only (HR = 2.00; 95% CI: 1.29–3.12) had increased the risk of progression from prediabetes to diabetes.
Conclusions
The effect of sarcopenic obesity on the progression of glycaemic status based on fasting plasma glucose and glycated haemoglobin may be more pronounced than that of sarcopenia only or obesity only.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Förderung
- Fundamental Research Funds for the Central Universities, Huazhong University of Science and Technology
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Lou, Y., Xie, Y., Jiang, Q., Huang, S., Wang, X., Wang, L., Wang, H., & Cao, S. (2025). The effect of sarcopenic obesity on glycaemic status based on fasting plasma glucose and glycated haemoglobin: A prospective cohort study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16016
Vancouver
Lou Y, Xie Y, Jiang Q, Huang S, Wang X, Wang L, et al. The effect of sarcopenic obesity on glycaemic status based on fasting plasma glucose and glycated haemoglobin: A prospective cohort study. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16016
BibTeX
@article{Lou2025,
author = {Lou, Yiling and Xie, Yulin and Jiang, Qingqing and Huang, Shen and Wang, Xiaohan and Wang, Linlin and Wang, Hengchang and Cao, Shiyi},
title = {The effect of sarcopenic obesity on glycaemic status based on fasting plasma glucose and glycated haemoglobin: A prospective cohort study},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16016}
}
EUVIMED